Antimicrobial Revision in Persistent Febrile Neutropenia
Status:
Not yet recruiting
Trial end date:
2024-11-01
Target enrollment:
Participant gender:
Summary
Febrile neutropenia is often seen in patients with hematologic malignancies who receive
cytotoxic chemotherapy. These patients are usually placed on posaconazole prophylaxis upon
starting chemotherapy. If an episode of febrile neutropenia occurs, generally an
anti-pseudomonal beta lactam, like cefepime or piperacillin-tazobactam, is initiated. In
patients who continue to fever on these agents, the optimal method of antimicrobial revision
has yet to be determined.